DIVIDEND ANNOUNCEMENT: Amgen Inc (NASDAQ:AMGN) on 10/28/2022 declared a dividend of $1.9400 per share

Amgen Inc (NASDAQ:AMGN) on 10/28/2022 declared a dividend of $ 1.9400 per share payable on December 08, 2022 to shareholders of record as of November 17, 2022.

Amgen Inc (NASDAQ:AMGN) has paid dividends since 1997, has a current dividend yield of 2.9038655758% and has increased its dividends for 10 successive years.

Amgen Inc's market cap is $ 142,949,611,130 and has a PE ratio of 22.67. The stock price closed yesterday at $ 267.23 and has a 52 week low/high of $ 198.64 and $ 269.31.

Amgen is a biotechnology company that focuses on discovering, developing, manufacturing and delivering human therapeutics. Co.'s principal products are Enbrel® (etanercept), Prolia® (denosumab), Otezla® (apremilast), XGEVA® (denosumab), Neulasta® (pegfilgrastim), Aranesp® (darbepoetin alfa), Repatha® (evolocumab), KYPROLIS® (carfilzomib) and Nplate® (romiplostim). Co. also markets a number of other products, including among other, MVASI® (bevacizumab-awwb), Vectibix® (panitumumab), KANJINTI® (trastuzumab-anns), EVENITY® (romosozumab-aqqg), EPOGEN® (epoetin alfa), BLINCYTO® (blinatumomab), AMGEVITA™ (adalimumab), Aimovig® (erenumab-aooe), Parsabiv® (etelcalcetide) and NEUPOGEN® (filgrastim).

For more information on Amgen Inc click here.